{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:24:37Z","timestamp":1790641477143,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"crossref","award":["Clinician Scientist Program Grant: #386-0-0"],"award-info":[{"award-number":["Clinician Scientist Program Grant: #386-0-0"]}],"id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"crossref","award":["fort\u00fcne program (#2554-0-0)."],"award-info":[{"award-number":["fort\u00fcne program (#2554-0-0)."]}],"id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"crossref","award":["fort\u00fcne program (#2554-0-0)."],"award-info":[{"award-number":["fort\u00fcne program (#2554-0-0)."]}],"id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"crossref","award":["Clinician Scientist Program Grant: #434-0-0"],"award-info":[{"award-number":["Clinician Scientist Program Grant: #434-0-0"]}],"id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["Open Access Publishing Fund of University of T\u00fcbingen"],"award-info":[{"award-number":["Open Access Publishing Fund of University of T\u00fcbingen"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["418081722"],"award-info":[{"award-number":["418081722"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Reference Network for Rare Neurological Diseases","award":["Project ID No 739510"],"award-info":[{"award-number":["Project ID No 739510"]}]},{"name":"European Reference Network for Rare Neurological Diseases","award":["Project ID No 739510"],"award-info":[{"award-number":["Project ID No 739510"]}]},{"name":"European Reference Network for Rare Neurological Diseases","award":["Project ID No 739510"],"award-info":[{"award-number":["Project ID No 739510"]}]},{"name":"European Reference Network for Rare Neurological Diseases","award":["Project ID No 739510"],"award-info":[{"award-number":["Project ID No 739510"]}]},{"name":"European Reference Network for Rare Neurological Diseases","award":["Project ID No 739510"],"award-info":[{"award-number":["Project ID No 739510"]}]},{"name":"European Reference Network for Rare Neurological Diseases","award":["Project ID No 739510"],"award-info":[{"award-number":["Project ID No 739510"]}]},{"name":"European Reference Network for Rare Neurological Diseases","award":["Project ID No 739510"],"award-info":[{"award-number":["Project ID No 739510"]}]},{"name":"European Reference Network for Rare Neurological Diseases","award":["Project ID No 739510"],"award-info":[{"award-number":["Project ID No 739510"]}]},{"name":"Ministry of Science, Research and the Arts of Baden-W\u00fcrttemberg","award":["31-7635"],"award-info":[{"award-number":["31-7635"]}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"crossref","award":["41\/67\/1"],"award-info":[{"award-number":["41\/67\/1"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    X-linked Adrenoleukodystrophy (X-ALD) is caused by mutations in the\n                    <jats:italic>ABCD1<\/jats:italic>\n                    gene resulting in the accumulation of very long chain fatty acids (VLCFA). X-ALD is the most common peroxisomal disorder with adult patients (male and female) presenting with progressive spastic paraparesis with bladder disturbance, sensory ataxia with impaired vibration sense, and leg pain. 80% of male X-ALD patients have an adrenal failure, while adrenal dysfunction is rare in women with X-ALD. The objective of this study was to define optimal serum VLCFA cutoff values in patients with X-ALD-like phenotypes for the differentiation of genetically confirmed X-ALD and Non-X-ALD individuals. Three groups were included into this study: a) X-ALD cases with confirmed\n                    <jats:italic>ABCD1<\/jats:italic>\n                    mutations (n\u2009=\u200934) and two Non-X-ALD cohorts: b) Patients with abnormal serum VCLFA levels despite negative testing for\n                    <jats:italic>ABCD1<\/jats:italic>\n                    mutations (n\u2009=\u200915) resulting from a total of 1,953 VLCFA tests c) Phenotypically matching patients as Non-X-ALD controls (n\u2009=\u2009104). Receiver operating curve analysis was used to optimize VLCFA cutoff values, which differentiate patients with genetically confirmed X-ALD and Non-X-ALD individuals. The serum concentration of C26:0 was superior to C24:0 for the detection of X-ALD. The best differentiation of Non-X-ALD and X-ALD individuals was obtained with a cutoff value of\u2009&lt;\u20091.0 for the C24:0\/C22:0 ratio resulting in a sensitivity of 97%, a specificity of 94.1% and a positive predictive value (PPV) of 83.8% for true X-ALD. Our findings further suggested a cutoff of\u2009&lt;\u20090.02 for the ratio C26:0\/C22:0 leading to a sensitivity of 90.9%, a specificity of 95.0%, and a PPV of 80.6%. Pearson correlation indicated a significant positive association between total blood cholesterol and VLCFA values. Usage of serum VLCFA are economical and established biomarkers suitable for the guidance of genetic testing matching the X-ALD phenotype. We suggest using our new optimized cutoff values, especially the two ratios (C24:0\/C22:0 and C26:0\/C22:0), in combination with standard lipid profiles.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-71248-8","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T06:03:33Z","timestamp":1600149813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy"],"prefix":"10.1038","volume":"10","author":[{"given":"Tim W.","family":"Rattay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Rautenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"S\u00f6hn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Trasch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"R\u00f6ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie N.","family":"Hayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wiethoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Zeltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias B.","family":"Haack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Cegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Sch\u00f6ls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Schleicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"71248_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/ncpneuro0421","volume":"3","author":"HW Moser","year":"2007","unstructured":"Moser, H. W., Mahmood, A. & Raymond, G. V. X-linked adrenoleukodystrophy. Nat. Clin. Pract. Neurol. 3, 140\u2013151 (2007).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"71248_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1172-7-51","volume":"7","author":"M Engelen","year":"2012","unstructured":"Engelen, M. et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J. Rare Dis. 7, 51. https:\/\/doi.org\/10.1186\/1750-1172-7-51 (2012).","journal-title":"Orphanet J. Rare Dis."},{"key":"71248_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/361726a0","volume":"361","author":"J Mosser","year":"1993","unstructured":"Mosser, J. et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with Abc transporters. Nature 361, 726\u2013730. https:\/\/doi.org\/10.1038\/361726a0 (1993).","journal-title":"Nature"},{"key":"71248_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.61.2.181","volume":"61","author":"V Chaudhry","year":"1996","unstructured":"Chaudhry, V., Moser, H. W. & Cornblath, D. R. Nerve conduction studies in adrenomyeloneuropathy. J. Neurol. Neurosurg. Psychiatry 61, 181\u2013185 (1996).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"71248_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13023-018-0939-7","volume":"13","author":"TW Rattay","year":"2018","unstructured":"Rattay, T. W. et al. Nerve ultrasound characterizes AMN polyneuropathy as inhomogeneous and focal hypertrophic. Orphanet J. Rare Dis. 13, 194. https:\/\/doi.org\/10.1186\/s13023-018-0939-7 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"71248_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.parkreldis.2019.06.008","volume":"65","author":"Y-J Chen","year":"2019","unstructured":"Chen, Y.-J. et al. Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia. Parkinsonism Related Disord. 65, 256\u2013260. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.008 (2019).","journal-title":"Parkinsonism Related Disord."},{"key":"71248_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00981","author":"A D'Amore","year":"2018","unstructured":"D\u2019Amore, A. et al. Next generation molecular diagnosis of hereditary spastic paraplegias: an italian cross-sectional study. Front. Neurol. https:\/\/doi.org\/10.3389\/fneur.2018.00981 (2018).","journal-title":"Front. Neurol."},{"key":"71248_CR8","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3389\/fneur.2018.00958","volume":"9","author":"DM Bis-Brewer","year":"2018","unstructured":"Bis-Brewer, D. M. & Zuchner, S. Perspectives on the Genomics of HSP Beyond Mendelian Inheritance. Front. Neurol. 9, 958. https:\/\/doi.org\/10.3389\/fneur.2018.00958 (2018).","journal-title":"Front. Neurol."},{"key":"71248_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/ncpneuro0421","volume":"3","author":"HW Moser","year":"2007","unstructured":"Moser, H. W., Mahmood, A. & Raymond, G. V. X-linked adrenoleukodystrophy. Nat. Rev. Neurol. 3, 140 (2007).","journal-title":"Nat. Rev. Neurol."},{"key":"71248_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U","volume":"45","author":"AB Moser","year":"1999","unstructured":"Moser, A. B. et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 45, 100\u2013110 (1999).","journal-title":"Ann. Neurol."},{"key":"71248_CR11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-2275(20)38861-1","volume":"27","author":"G Lepage","year":"1986","unstructured":"Lepage, G. & Roy, C. C. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 27, 114\u2013120 (1986).","journal-title":"J. Lipid Res."},{"key":"71248_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/s0006-3223(98)00043-2","volume":"44","author":"F Curtin","year":"1998","unstructured":"Curtin, F. & Schulz, P. Multiple correlations and Bonferroni\u2019s correction. Biol. Psychiat. 44, 775\u2013777. https:\/\/doi.org\/10.1016\/s0006-3223(98)00043-2 (1998).","journal-title":"Biol. Psychiat."},{"key":"71248_CR13","first-page":"bcr1120092419","volume":"2010","author":"BK Morell","year":"2010","unstructured":"Morell, B. K., Teichler, J., Budak, K., Vollenweider, J. & Pavlicek, V. X-linked adrenoleukodystrophy presenting as Addison\u2019s disease. Case Rep. 2010, bcr1120092419 (2010).","journal-title":"Case Rep."},{"key":"71248_CR14","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1212\/Wnl.31.10.1241","volume":"31","author":"HW Moser","year":"1981","unstructured":"Moser, H. W. et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology 31, 1241\u20131241. https:\/\/doi.org\/10.1212\/Wnl.31.10.1241 (1981).","journal-title":"Neurology"},{"key":"71248_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/TACG.S49590","volume":"8","author":"C Wiesinger","year":"2015","unstructured":"Wiesinger, C., Eichler, F. S. & Berger, J. The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. Appl. Clin. Genet. 8, 109. https:\/\/doi.org\/10.2147\/TACG.S49590 (2015).","journal-title":"Appl. Clin. Genet."},{"key":"71248_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF02536332","volume":"29","author":"M Martinez","year":"1994","unstructured":"Martinez, M., Mougan, I., Roig, M. & Ballabriga, A. Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study. Lipids 29, 273\u2013280. https:\/\/doi.org\/10.1007\/BF02536332 (1994).","journal-title":"Lipids"},{"key":"71248_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.24611","volume":"79","author":"R Sch\u00fcle","year":"2016","unstructured":"Sch\u00fcle, R. et al. Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients. Ann. Neurol. 79, 646\u2013658. https:\/\/doi.org\/10.1002\/ana.24611 (2016).","journal-title":"Ann. Neurol."},{"key":"71248_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ymgme.2011.05.016","volume":"104","author":"Y Wang","year":"2011","unstructured":"Wang, Y. et al. X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism. Mol. Genet. Metab. 104, 160\u2013166. https:\/\/doi.org\/10.1016\/j.ymgme.2011.05.016 (2011).","journal-title":"Mol. Genet. Metab."},{"key":"71248_CR19","first-page":"1135","volume":"58","author":"V Feigenbaum","year":"1996","unstructured":"Feigenbaum, V. et al. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. Am. J. Hum. Genet. 58, 1135\u20131144 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"71248_CR20","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.cca.2011.08.026","volume":"412","author":"P Shukla","year":"2011","unstructured":"Shukla, P. et al. Molecular analysis of ABCD1 gene in Indian patients with X-linked Adrenoleukodystrophy. Clin. Chim. Acta 412, 2289\u20132295. https:\/\/doi.org\/10.1016\/j.cca.2011.08.026 (2011).","journal-title":"Clin. Chim. Acta"},{"key":"71248_CR21","doi-asserted-by":"publisher","first-page":"e34195","DOI":"10.1371\/journal.pone.0034195","volume":"7","author":"FdS Pereira","year":"2012","unstructured":"Pereira, F. d. S. et al. Mutations, clinical findings and survival estimates in South American patients with X-linked adrenoleukodystrophy. PLOS ONE 7, e34195. https:\/\/doi.org\/10.1371\/journal.pone.0034195 (2012).","journal-title":"PLOS ONE"},{"key":"71248_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-3476(83)80775-6","volume":"103","author":"HW Moser","year":"1983","unstructured":"Moser, H. W., Moser, A. E., Trojak, J. E. & Supplee, S. W. Identification of female carriers of adrenoleukodystrophy. J. Pediatrics 103, 54\u201359. https:\/\/doi.org\/10.1016\/S0022-3476(83)80775-6 (1983).","journal-title":"J. Pediatrics"},{"key":"71248_CR23","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1471-4159.1981.tb01657.x","volume":"36","author":"T Ogino","year":"1981","unstructured":"Ogino, T. & Suzuki, K. Specificities of human and rat brain enzymes of cholesterol ester metabolism toward very long chain fatty acids: implication for biochemical pathogenesis of adrenoleukodystrophy. J. Neurochem. 36, 776\u2013779 (1981).","journal-title":"J. Neurochem."},{"key":"71248_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ymgme.2004.06.015","volume":"83","author":"Z Jia","year":"2004","unstructured":"Jia, Z. et al. X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases. Mol. Genet. Metab. 83, 117\u2013127 (2004).","journal-title":"Mol. Genet. Metab."},{"key":"71248_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0022-510X(92)90028-J","volume":"110","author":"C Theda","year":"1992","unstructured":"Theda, C., Moser, A. B., Powers, J. M. & Moser, H. W. Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination. J. Neurol. Sci. 110, 195\u2013204 (1992).","journal-title":"J. Neurol. Sci."},{"key":"71248_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/adc.86.3.185","volume":"86","author":"MD Ronghe","year":"2002","unstructured":"Ronghe, M. D. et al. The importance of testing for adrenoleucodystrophy in males with idiopathic Addison\u2019s disease. Arch. Dis. Child. 86, 185\u2013189. https:\/\/doi.org\/10.1136\/adc.86.3.185 (2002).","journal-title":"Arch. Dis. Child."},{"key":"71248_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/cen.12159","volume":"79","author":"MA Horn","year":"2013","unstructured":"Horn, M. A. et al. Screening for X-linked adrenoleukodystrophy among adult men with Addison\u2019s disease. Clin. Endocrinol. 79, 316\u2013320. https:\/\/doi.org\/10.1111\/cen.12159 (2013).","journal-title":"Clin. Endocrinol."},{"key":"71248_CR28","first-page":"373","volume":"24","author":"S Streck","year":"2000","unstructured":"Streck, S., Winnefeld, K., Maurer, I. & Volz, H.-P. Die quantitative Bestimmung ausgew\u00e4hlter langkettiger Fetts\u00e4uren und sehr langkettiger Fetts\u00e4uren (VLCFA) im Serum. The Quantitative Determination of Selected Long Chain and Very Long Chain Fatty Acids (VLCFA) in Serum. LaboratoriumsMedizin\/J. Lab. Med. 24, 373\u2013376 (2000).","journal-title":"LaboratoriumsMedizin\/J. Lab. Med."},{"key":"71248_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0009-8981(90)90077-6","volume":"192","author":"F Stellaard","year":"1990","unstructured":"Stellaard, F., ten Brink, H., Kok, R., Van Den Heuvel, L. & Jakobs, C. Stable isotope dilution analysis of very long chain fatty acids in plasma, urine and amniotic fluid by electron capture negative ion mass fragmentography. Clin. Chim. Acta 192, 133\u2013144 (1990).","journal-title":"Clin. Chim. Acta"},{"key":"71248_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1006\/mgme.2001.3170","volume":"73","author":"SA Lagerstedt","year":"2001","unstructured":"Lagerstedt, S. A. et al. Quantitative determination of plasma c8\u2013c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol. Genet. Metab. 73, 38\u201345 (2001).","journal-title":"Mol. Genet. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71248-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71248-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71248-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:59:36Z","timestamp":1670335176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71248-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["71248"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-71248-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15093"}}